Amdocs Limited Stock Fundamentals
| AOS Stock | 81.32 0.02 0.02% |
Amdocs Limited fundamentals help investors to digest information that contributes to Amdocs' financial success or failures. It also enables traders to predict the movement of Amdocs Stock. The fundamental analysis module provides a way to measure Amdocs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amdocs stock.
Amdocs |
Amdocs Limited Company EBITDA Analysis
Amdocs' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Amdocs EBITDA | 889.85 M |
Most of Amdocs' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Amdocs Limited reported earnings before interest,tax, depreciation and amortization of 889.85 M. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.
Amdocs Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amdocs's current stock value. Our valuation model uses many indicators to compare Amdocs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amdocs competition to find correlations between indicators driving Amdocs's intrinsic value. More Info.Amdocs Limited is rated below average in current valuation category among its peers. It is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Amdocs Limited is about 3,358,391,531 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amdocs' earnings, one of the primary drivers of an investment's value.Amdocs EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.Amdocs is currently under evaluation in ebitda category among its peers.
Amdocs Fundamentals
| Current Valuation | 10.2 B | |||
| Price To Book | 3.04 X | |||
| Price To Sales | 2.37 X | |||
| Revenue | 4.58 B | |||
| EBITDA | 889.85 M | |||
| Net Income | 549.5 M | |||
| Total Debt | 645.12 M | |||
| Cash Flow From Operations | 756.72 M | |||
| Price To Earnings To Growth | 1.15 X | |||
| Market Capitalization | 8.08 B | |||
| Total Asset | 6.39 B | |||
| Z Score | 7.2 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 6.39 B |
About Amdocs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amdocs Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amdocs Stock Analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.